| Year |
Citation |
Score |
| 2016 |
Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Journal of Neurosurgery. 1-13. PMID 27419830 DOI: 10.3171/2016.1.Jns152077 |
0.448 |
|
| 2015 |
van Ginkel PR, Yan MB, Bhattacharya S, Polans AS, Kenealey JD. Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells. Toxicology and Applied Pharmacology. 288: 453-62. PMID 26341291 DOI: 10.1016/J.Taap.2015.08.016 |
0.726 |
|
| 2014 |
Kanavi MR, Darjatmoko S, Wang S, Azari AA, Farnoodian M, Kenealey JD, van Ginkel PR, Albert DM, Sheibani N, Polans AS. The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization. Molecules (Basel, Switzerland). 19: 17578-603. PMID 25361423 DOI: 10.3390/Molecules191117578 |
0.689 |
|
| 2014 |
Clark P, Bhattacharya S, Ginkel Pv, Darjatmoko S, Elmayam A, Polans A, Kuo J. ET-11RESVERATROL REGULATES GLIOBLASTOMA AND GLIOBLASTOMA STEM-LIKE CELLS VIA ANTI-TUMORIGENIC AKT DEPHOSPHORYLATION AND p53 ACTIVATION Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou255.11 |
0.439 |
|
| 2011 |
Soto BL, Hank JA, Darjatmoko SR, Polans AS, Yanke EM, Rakhmilevich AL, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM. Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy. International Immunopharmacology. 11: 1877-86. PMID 21854876 DOI: 10.1016/J.Intimp.2011.07.019 |
0.472 |
|
| 2011 |
Bhattacharya S, Darjatmoko SR, Polans AS. Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. Melanoma Research. 21: 180-7. PMID 21407133 DOI: 10.1097/Cmr.0B013E3283456Dfc |
0.409 |
|
| 2011 |
Kenealey JD, Subramanian L, Van Ginkel PR, Darjatmoko S, Lindstrom MJ, Somoza V, Ghosh SK, Song Z, Hsung RP, Kwon GS, Eliceiri KW, Albert DM, Polans AS. Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells. Journal of Agricultural and Food Chemistry. 59: 4979-86. PMID 21401048 DOI: 10.1021/Jf104901G |
0.732 |
|
| 2011 |
Soto BL, Hank JA, Van De Voort TJ, Subramanian L, Polans AS, Rakhmilevich AL, Yang RK, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM. The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model. Cancer Immunology, Immunotherapy : Cii. 60: 731-8. PMID 21340652 DOI: 10.1007/S00262-011-0971-0 |
0.585 |
|
| 2011 |
Benassi I, Rauguth I, Bhattacharya S, Polans AS, Feirer R. Abstract 4214: Resveratrol: Effect on polyamine metabolism and synergistic interactions with DFMO and DenSpm in breast cancer and uveal melanoma cell lines Cancer Research. 71: 4214-4214. DOI: 10.1158/1538-7445.Am2011-4214 |
0.407 |
|
| 2010 |
Subramanian L, Youssef S, Bhattacharya S, Kenealey J, Polans AS, van Ginkel PR. Resveratrol: challenges in translation to the clinic--a critical discussion. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5942-8. PMID 21045084 DOI: 10.1158/1078-0432.Ccr-10-1486 |
0.716 |
|
| 2010 |
Soto BL, Hank JA, Polans AS, Voort Tvd, Rakhmilevich AL, Seo S, Kuyungmann K, Gillies SD, Sondel PM. Abstract LB-325: Antitumor effect of resveratrol combined with immunocytokine immunotherapy Immunology. 70. DOI: 10.1158/1538-7445.Am10-Lb-325 |
0.303 |
|
| 2008 |
van Ginkel PR, Darjatmoko SR, Sareen D, Subramanian L, Bhattacharya S, Lindstrom MJ, Albert DM, Polans AS. Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction. Investigative Ophthalmology & Visual Science. 49: 1299-306. PMID 18385041 DOI: 10.1167/Iovs.07-1233 |
0.684 |
|
| 2007 |
Sareen D, Darjatmoko SR, Albert DM, Polans AS. Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Molecular Pharmacology. 72: 1466-75. PMID 17848600 DOI: 10.1124/Mol.107.039040 |
0.634 |
|
| 2007 |
van Ginkel PR, Sareen D, Subramanian L, Walker Q, Darjatmoko SR, Lindstrom MJ, Kulkarni A, Albert DM, Polans AS. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5162-9. PMID 17785572 DOI: 10.1158/1078-0432.Ccr-07-0347 |
0.7 |
|
| 2006 |
Sareen D, van Ginkel PR, Takach JC, Mohiuddin A, Darjatmoko SR, Albert DM, Polans AS. Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells. Investigative Ophthalmology & Visual Science. 47: 3708-16. PMID 16936077 DOI: 10.1167/Iovs.06-0119 |
0.644 |
|
| 2004 |
Subramanian L, Crabb JW, Cox J, Durussel I, Walker TM, van Ginkel PR, Bhattacharya S, Dellaria JM, Palczewski K, Polans AS. Ca2+ binding to EF hands 1 and 3 is essential for the interaction of apoptosis-linked gene-2 with Alix/AIP1 in ocular melanoma. Biochemistry. 43: 11175-86. PMID 15366927 DOI: 10.1021/Bi048848D |
0.548 |
|
| 2004 |
Subramanian L, Polans AS. Cancer-related diseases of the eye: the role of calcium and calcium-binding proteins. Biochemical and Biophysical Research Communications. 322: 1153-65. PMID 15336963 DOI: 10.1016/J.Bbrc.2004.07.109 |
0.604 |
|
| 2004 |
van Ginkel PR, Gee RL, Shearer RL, Subramanian L, Walker TM, Albert DM, Meisner LF, Varnum BC, Polans AS. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Research. 64: 128-34. PMID 14729616 DOI: 10.1158/0008-5472.Can-03-0245 |
0.612 |
|
| 2002 |
Walker TM, Van Ginkel PR, Gee RL, Ahmadi H, Subramanian L, Ksander BR, Meisner LF, Albert DM, Polans AS. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Archives of Ophthalmology (Chicago, Ill. : 1960). 120: 1719-25. PMID 12470148 DOI: 10.1001/Archopht.120.12.1719 |
0.484 |
|
| 2000 |
Polans AS, Gee RL, Walker TM, van Ginkel PR. Calcium-binding proteins and their assessment in ocular diseases. Methods in Enzymology. 316: 103-21. PMID 10800671 DOI: 10.1016/S0076-6879(00)16719-9 |
0.342 |
|
| 1998 |
Van Ginkel PR, Gee RL, Walker TM, Hu DN, Heizmann CW, Polans AS. The identification and differential expression of calcium-binding proteins associated with ocular melanoma. Biochimica Et Biophysica Acta. 1448: 290-7. PMID 9920419 DOI: 10.1016/S0167-4889(98)00133-5 |
0.422 |
|
| 1997 |
Johnson WC, Palczewski K, Gorczyca WA, Riazance-Lawrence JH, Witkowska D, Polans AS. Calcium binding to recoverin: implications for secondary structure and membrane association. Biochimica Et Biophysica Acta. 1342: 164-74. PMID 9392525 DOI: 10.1016/S0167-4838(97)00091-5 |
0.309 |
|
| 1996 |
Polans A, Baehr W, Palczewski K. Turned on by Ca2+! The physiology and pathology of Ca2+-binding proteins in the retina Trends in Neurosciences. 19: 547-554. PMID 8961484 DOI: 10.1016/S0166-2236(96)10059-X |
0.309 |
|
| 1995 |
Gorczyca WA, Polans AS, Surgucheva IG, Subbaraya I, Baehr W, Palczewski K. Guanylyl cyclase activating protein: A calcium-sensitive regulator of phototransduction Journal of Biological Chemistry. 270: 22029-22036. PMID 7665624 DOI: 10.1074/Jbc.270.37.22029 |
0.305 |
|
| 1995 |
Polans AS, Witkowska D, Haley TL, Amundson D, Baizer L, Adamus G. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy Proceedings of the National Academy of Sciences of the United States of America. 92: 9176-9180. PMID 7568096 DOI: 10.1073/Pnas.92.20.9176 |
0.393 |
|
| 1995 |
Polans AS, Adamus G. Recoverin is the tumor antigen in cancer-associated retinopathy Behavioral and Brain Sciences. 18: 483-484. DOI: 10.1017/S0140525X00039406 |
0.415 |
|
| 1994 |
Adamus G, Ortega H, Witkowska D, Polans A. Recoverin: a potent uveitogen for the induction of photoreceptor degeneration in Lewis rats. Experimental Eye Research. 59: 447-456. PMID 7859820 DOI: 10.1006/Exer.1994.1130 |
0.313 |
|
| 1993 |
Gray-Keller MP, Polans AS, Palczewski K, Detwiler PB. The effect of recoverin-like calcium-binding proteins on the photoresponse of retinal rods. Neuron. 10: 523-31. PMID 8461139 DOI: 10.1016/0896-6273(93)90339-S |
0.316 |
|
| 1993 |
Polans AS, Crabb JW, Palczewski K. Calcium-Binding Proteins in the Retina Methods in Neurosciences. 15: 248-260. DOI: 10.1016/B978-0-12-185279-5.50023-6 |
0.325 |
|
| 1991 |
Polans AS, Buczyłko J, Crabb J, Palczewski K. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy Journal of Cell Biology. 112: 981-989. PMID 1999465 DOI: 10.1083/Jcb.112.5.981 |
0.34 |
|
| Show low-probability matches. |